The complementary binding arms recognize matching regions in the RNA substrate and help hold the target in a defined geometry. This positioning brings the RNA-containing junction into the catalytic core, where cleavage can occur. The arrangement links sequence recognition to catalytic activity, so changing the target sequence or arm design can alter which RNA is engaged.
Specificity depends not only on recognizing an RNA sequence but also on placing a susceptible ribonucleotide junction at the intended cutting site. When the arms position that junction within the core, cleavage can be directed to a selected location rather than occurring indiscriminately. This feature makes the approach useful for examining consequences of cutting particular RNA regions.
Divalent metal ions support the chemistry of phosphodiester-bond cleavage within the catalytic core. Their presence helps the DNAzyme promote cutting after the RNA substrate has been correctly positioned, connecting molecular recognition with catalytic output. Consequently, ion conditions are a key part of the system’s operating environment and can influence whether sequence recognition produces detectable cleavage.
A design begins with a single-stranded DNA molecule containing a catalytic core and complementary binding arms, together with an RNA substrate that presents the intended junction. The setup must also account for divalent metal ions, which support cleavage chemistry. Researchers can then evaluate whether recognition and positioning lead to cutting at the selected RNA site.
Biologists can use these molecules to investigate RNA function and gene regulation when they need sequence-selective cleavage without relying on a protein enzyme. Directing cleavage toward a chosen RNA sequence can help connect that RNA to a regulatory or functional outcome. The approach is therefore relevant to studies that ask how particular RNA molecules influence cellular biology.
In biosensor designs, target-RNA recognition can be converted into a measurable signal through the cleavage reaction, allowing molecular detection to be linked to catalytic activity. The same programmable specificity, compact design, and stability make RNA-cleaving DNAzymes candidates for therapeutic and diagnostic research. These uses extend the method beyond mechanistic RNA studies into signal generation and applied development.